Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.
Gå till den engelska sidanWeekly edition
The 10 most notable cure or vaccine studies from the last week.
Early trial testing a one-time gene therapy for babies with Artemis SCID, a severe immune disease. Uses patient's own corrected cells.
Read lead report →A clinical trial testing a gentler bone marrow transplant to cure children with severe sickle cell disease while reducing side effects.
Read report →A trial testing a single oral pill to cure sleeping sickness in children aged 1-14 in Africa. It aims to replace complex hospital treatments.
Read report →A clinical trial testing a modified stem cell transplant procedure for Chronic Granulomatous Disease (CGD) to improve success rates and reduce complications.
Read report →Phase 3 study testing a chikungunya vaccine's safety and immune response in 720 children aged 1-12. Currently recruiting participants.
Read report →Phase 3 study testing a 5th booster dose of the VLA15 Lyme disease vaccine in healthy people aged 7+ who have already had 4 doses.
Read report →Phase 3 trial testing a new meningitis vaccine in 1,040 healthy children aged 12-23 months. Compares immune response and safety to an existing vaccine.
Read report →Phase 3 study testing Moderna's mRNA pandemic flu vaccine in 4,000 adults. Measures immune response, safety, and side effects.
Read report →First human trial testing a new monkeypox vaccine in 180 healthy adults. Study focuses on safety and immune response.
Read report →Early-stage study testing safety and immune response of a new meningitis B vaccine in 30 healthy adults. Not yet recruiting participants.
Read report →